Matthew I. Gerstein, M.D.

Matthew I. Gerstein, M.D.

Urologists

Matthew Gerstein, M.D. is board certified by the American Board of Urology. A graduate of Cornell University, he obtained his medical degree at the State University of New York in Brooklyn (Downstate) and completed both his general surgical and urologic residencies at Temple University in Philadelphia, Pennsylvania. Since completion of his residency, Dr. Gerstein has been practicing Urology and serving patients in both Bucks and Montgomery Counties. He is a member of various national and local professional societies.

Dr. Gerstein treats patients with a broad array of urologic diseases and has particular interest in laparoscopic surgery, kidney stone disease, urologic oncology and minimally invasive procedures. In addition, he performs procedures for stress incontinence, BPH and erectile dysfunction.

Academic Urology Locations

  • Lansdale

    1000 Walnut Street
    Suite 122
    Lansdale, PA 19446
    --

  • Sellersville

    711 Lawn Avenue
    Building 2
    Sellersville, PA 18960
    215-257-1050

Hospital Affiliations

Video

Our Recent News

Prostate Center Patients Celebrate Survivors' Day

Sunday June 4, 2017

Over 400 people--patients and family members--joined physicians and staff from the Academic Urology Prostate Center and Fox Chase Cancer Center Medical Group on June 4th at the Valley Forge Casino & Resort in King of Prussia to mark the annual National Cancer Survivors’ Day.

Read More »

Prostate Center Patients Celebrate Survivors' Day

Monday July 25, 2016

Almost 400 people—patients and family members—joined physicians and staff from the Academic Urology Prostate Center on June 5 at the Presidential Catering center in East Norriton to mark the annual National Cancer Survivors’ Day.

Read More »

Academic Urology Research Explores Treatment Options for Advanced Prostate Cancer

Monday December 14, 2015

Physicians at Academic Urology are enrolling patients in a new study of treatment options for men with castration-resistant prostate cancer (CRPC).

Read More »